This is great news as our Deoxymabs will be able to help treat diseases outside of cancer widening our market greatly.
If we get past the GMP and do our ph1 we'll have partners queueing up.
Ann: Presentation to highlight broader potential of Deoxymabs, page-6
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $16.46M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $87 | 12.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 8089083 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 2630083 | 4 |
View Market Depth
| Last trade - 14.01pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.7¢ |
Change
-0.001 ( 6.67 %) |
||||
| Open | High | Low | Volume | ||
| 0.7¢ | 0.7¢ | 0.7¢ | 23260 | ||
| Last updated 14.25pm 05/06/2024 ? | |||||
| PAB (ASX) Chart |